European Journal of Preventive Cardiology

Article	Citations
Burden of heart failure and underlying causes in 195 countries and territories from 1990 to 2017	324
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice	253
Exercise intensity assessment and prescription in cardiovascular rehabilitation and beyond: why and how: a position statement from the Secondary Prevention and Rehabilitation Section of the European A	135
Obesity and cardiovascular disease: mechanistic insights and management strategies. A joint position paper by the World Heart Federation and World Obesity Federation	110
Frailty in cardiology: definition, assessment and clinical implications for general cardiology. A consensus document of the Council for Cardiology Practice (CCP), Association for Acute Cardio Vascular	97
Burden of ischemic heart disease and its attributable risk factors in 204 countries and territories, 1990–2019	94
Effectiveness of home-based cardiac telerehabilitation as an alternative to Phase 2 cardiac rehabilitation of coronary heart disease: a systematic review and meta-analysis	93
Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic	92
Personalized exercise prescription in the prevention and treatment of arterial hypertension: a Consensus Document from the European Association of Preventive Cardiology (EAPC) and the ESC Council on H	88
Impact of sarcopenia on prognosis in patients with heart failure with reduced and preserved ejection fraction	78
Improved oral hygiene care is associated with decreased risk of occurrence for atrial fibrillation and heart failure: A nationwide population-based cohort study	72
Statin use and risk of dementia or Alzheimer’s disease: a systematic review and meta-analysis of observational studies	70
Global trends and regional differences in incidence and mortality of cardiovascular disease, 1990−2019: findings from 2019 global burden of disease study	69
Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis	67
Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings	61
Role of gender, age and BMI in prognosis of heart failure	60
Statin therapy and lipoprotein(a) levels: a systematic review and meta-analysis	59
Life’s Essential 8 and the risk of cardiovascular disease death and all-cause mortality in Finnish men	55
Second consensus document on diagnosis and management of acute deep vein thrombosis: updated document elaborated by the ESC Working Group on aorta and peripheral vascular diseases and the ESC Working	53
Predicting the transition to and progression of heart failure with preserved ejection fraction: a weighted risk score using bio-humoural, cardiopulmonary, and echocardiographic stress testing	51
Poor adherence to lifestyle recommendations in patients with coronary heart disease: results from the EUROASPIRE surveys	49
Effect of sodium-glucose cotransporter-2 inhibitors on cardiac remodelling: a systematic review and meta-analysis	48
Effects of exercise rehabilitation in patients with long coronavirus disease 2019	46
How to optimize the adherence to a guideline-directed medical therapy in the secondary prevention of cardiovascular diseases: a clinical consensus statement from the European Association of Preventive	45
Utility of the CHA2DS2-VASc score for predicting ischaemic stroke in patients with or without atrial fibrillation: a systematic review and meta-analysis	44

Paediatric familial hypercholesterolaemia screening in Europe: public policy background and recommendations	42
‘Life’s Essential 8’ cardiovascular health with premature cardiovascular disease and all-cause mortality in young adults: the Kailuan prospective cohort study	41
Role of comorbidities in heart failure prognosis Part I: Anaemia, iron deficiency, diabetes, atrial fibrillation	40
The association between daily step count and all-cause and cardiovascular mortality: a meta-analysis	40
Tea consumption and the risk of atherosclerotic cardiovascular disease and all-cause mortality: The China-PAR project	40
Gut microbiome and risk of ischaemic stroke: a comprehensive Mendelian randomization study	38
Vascular ageing: moving from bench towards bedside	38
Triglyceride–glucose index in the development of heart failure and left ventricular dysfunction: analysis of the ARIC study	37
Cardiovascular effects of doping substances, commonly prescribed medications and ergogenic aids in relation to sports: a position statement of the sport cardiology and exercise nucleus of the European	36
Role of comorbidities in heart failure prognosis Part 2: Chronic kidney disease, elevated serum uric acid	35
External validation of the HCM Risk-Kids model for predicting sudden cardiac death in childhood hypertrophic cardiomyopathy	35
The role of exercise in the prevention of cancer therapy-related cardiac dysfunction in breast cancer patients undergoing chemotherapy: systematic review	34
Global magnitude and temporal trend of infective endocarditis, 1990–2019: results from the Global Burden of Disease Study	34
Participation in exercise-based cardiac rehabilitation is related to reduced total mortality in both men and women: results from the SWEDEHEART registry	34
Cardiovascular risk factors during cancer treatment. Prevalence and prognostic relevance: insights from the CARDIOTOX registry	33
Cardiovascular risk stratification by coronary computed tomography angiography imaging: current state-of-the-art	33
Impact of the COVID-19 pandemic on in-hospital mortality in cardiovascular disease: a meta-analysis	33
Future burden of cardiovascular disease in Australia: impact on health and economic outcomes between 2020 and 2029	32
The impact of coffee subtypes on incident cardiovascular disease, arrhythmias, and mortality: long-term outcomes from the UK Biobank	32
Combined use of trimethylamine N-oxide with BNP for risk stratification in heart failure with preserved ejection fraction: findings from the DIAMONDHFpEF study	32
Coffee consumption and mortality from cardiovascular diseases and total mortality: Does the brewing method matter?	32
Mental health-related risk factors and interventions in patients with heart failure: a position paper endorsed by the European Association of Preventive Cardiology (EAPC)	32
Joint association of physical activity and sleep duration with risk of all-cause and cause-specific mortality: a population-based cohort study using accelerometry	32
Obesity and metabolic health status are determinants for the clinical expression of hypertrophic cardiomyopathy	31
Finding very high lipoprotein(a): the need for routine assessment	31
Efficacy and safety of lomitapide in homozygous familial hypercholesterolaemia: the pan-European retrospective observational study	31
Stage 1 hypertension, sex, and acute coronary syndromes during midlife: the Hordaland Health Study	31
Home blood pressure during COVID-19-related lockdown in patients with hypertension	31
Global, regional, and national burden and quality of care index of endocarditis: the global burden of disease study 1990–2019	30
EAPC Core Curriculum for Preventive Cardiology	30
Self-reported daytime napping, daytime sleepiness, and other sleep phenotypes in the development of cardiometabolic diseases: a Mendelian randomization study	30
How spaceflight challenges human cardiovascular health	29
Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: the T.O.S.CA. Registry	29
Association between insulin resistance and risk of atrial fibrillation in non-diabetics	29
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterizatio	28
Heart failure is a common complication after acute myocardial infarction in patients with diabetes: A nationwide study in the SWEDEHEART registry	27
Multimodal prehabilitation as a promising strategy for preventing physical deconditioning on the heart transplant waiting list	27
Combined aerobic/resistance/inspiratory muscle training as the ‘optimum’ exercise programme for patients with chronic heart failure: ARISTOS-HF randomized clinical trial	27
Incremental prognostic value of non-alcoholic fatty liver disease over coronary computed tomography angiography findings in patients with suspected coronary artery disease	27
Protective effects of SGLT-2 inhibitors across the cardiorenal continuum: two faces of the same coin	27
Prediction of recurrent event in patients with coronary heart disease: the EUROASPIRE Risk Model	27
The association between short-term, chronic localized and chronic widespread pain and risk for cardiovascular disease in the UK Biobank	26
Relation of Life’s Essential 8 to the genetic predisposition for cardiovascular outcomes and all-cause mortality: results from a national prospective cohort	26
Short-term effects of particulate matter on cardiovascular morbidity in Italy: a national analysis	26
Joint association of physical activity and body mass index with cardiovascular risk: a nationwide population-based cross-sectional study	25
Efficacy and safety of colchicine for the prevention of major cardiovascular and cerebrovascular events in patients with coronary artery disease: a systematic review and meta-analysis on 12 869 patien	25
Half of patients with type 2 diabetes mellitus are at very high cardiovascular risk according to the ESC/EASD: data from a large Mediterranean population	25
Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP	25
European Society of Cardiology Quality Indicators for Cardiovascular Disease Prevention: developed by the Working Group for Cardiovascular Disease Prevention Quality Indicators in collaboration with t	24
Setting your clock: associations between timing of objective physical activity and cardiovascular disease risk in the general population	24

Dose–response effects of physical activity on all-cause mortality and major cardiorenal outcomes in chronic kidney disease	24
The DASH diet is associated with a lower risk of heart failure: a cohort study	24
Sinergy between drugs and devices in the fight against sudden cardiac death and heart failure	24
Hyperglycaemic disorders associated with PCSK9 inhibitors: a real-world, pharmacovigilance study	24
Cardioprotective effects of influenza vaccination among patients with established cardiovascular disease or at high cardiovascular risk: a systematic review and meta-analysis	23
Cardiac rehabilitation and all-cause mortality in patients with heart failure: a retrospective cohort study	23
Delphi consensus recommendations on how to provide cardiovascular rehabilitation in the COVID-19 era	23
Global, regional, and national quality of care of ischaemic heart disease from 1990 to 2017: a systematic analysis for the Global Burden of Disease Study 2017	23
Prognostic role of transferrin saturation in heart failure patients	23
Associations of genetic susceptibility and healthy lifestyle with incidence of coronary heart disease and stroke in individuals with hypertension	23
Addressing disparities of care in non-ST-segment elevation myocardial infarction patients without standard modifiable risk factors: insights from a nationwide cohort study	23
Human epicardial adipose tissue expresses glucose-dependent insulinotropic polypeptide, glucagon, and glucagon-like peptide-1 receptors as potential targets of pleiotropic therapies	22
Drug-resistant hypertension in primary aldosteronism patients undergoing adrenal vein sampling: the AVIS-2-RH study	22
Rationale and design of two trials assessing the efficacy, safety, and tolerability of inclisiran in adolescents with homozygous and heterozygous familial hypercholesterolaemia	22
Low-dose rivaroxaban and aspirin among patients with peripheral artery disease: a meta-analysis of the COMPASS and VOYAGER trials	22
Abdominal obesity and the risk of recurrent atherosclerotic cardiovascular disease after myocardial infarction	22
Gender gap in risk factor control of coronary patients far from closing: results from the European Society of Cardiology EUROASPIRE V registry	22
Global burden of rheumatic heart disease and its association with socioeconomic development status, 1990–2019	21
Insulin resistance drives cognitive impairment in hypertensive pre-diabetic frail elders: the CENTENNIAL study	21
Menopause modulates the circulating metabolome: evidence from a prospective cohort study	21
Causal relationships between the gut microbiome, blood lipids, and heart failure: a Mendelian randomization analysis	21
Light to moderate coffee consumption is associated with lower risk of death: a UK Biobank study	21
Functional capacity assessment and Minimal Clinically Important Difference in post-acute cardiac patients: the role of Short Physical Performance Battery	20
Cholesterol not particle concentration mediates the atherogenic risk conferred by apolipoprotein B particles: a Mendelian randomization analysis	20
Anticoagulation for atrial fibrillation in active cancer: what the cardiologists think	20
Less revascularization in young women but impaired long-term outcomes in young men after myocardial infarction	20
Remnant cholesterol, low-density lipoprotein cholesterol, and incident cardiovascular disease among Koreans: a national population-based study	20
Association of pre-pregnancy cardiovascular risk factor burden with adverse maternal and offspring outcomes	20
Time trends in ischaemic heart disease incidence and mortality over three decades (1990–2019) in 20 Western European countries: systematic analysis of the Global Burden of Disease Study 2019	20
Biventricular mechanical pattern of the athlete’s heart: comprehensive characterization using three-dimensional echocardiography	20
High visit-to-visit cholesterol variability predicts heart failure and adverse cardiovascular events: a population-based cohort study	20
Exercise-based cardiac rehabilitation vs. percutaneous coronary intervention for chronic coronary syndrome: impact on morbidity and mortality	20
Epidemiological and clinical boundaries of heart failure with preserved ejection fraction	19
Prevalence of diabetes and impact on cardiovascular events and mortality in patients with chronic coronary syndromes, across multiple geographical regions and ethnicities	19
Normative cardiopulmonary exercise data for endurance athletes: the Cardiopulmonary Health and Endurance Exercise Registry (CHEER)	19
Safety and efficacy of alirocumab in a real-life setting: the ODYSSEY APPRISE study	19
‘Weekend warrior’ and regularly active physical activity patterns confer similar cardiovascular and mortality benefits: a systematic meta-analysis	19
Sex differences on new-onset heart failure in patients with known or suspected coronary artery disease	19
Risk stratification in cardiomyopathy	18
Dipping pattern and short-term blood pressure variability are stronger predictors of cardiovascular events than average 24-h blood pressure in young hypertensive subjects	18
Neutrophil to platelet ratio: A novel prognostic biomarker in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention	18
Burden of cardiovascular risk factors and disease in five Asian groups in Catalonia: a disaggregated, population-based analysis of 121 000 first-generation Asian immigrants	18
Trends in blood pressure, blood lipids, and smoking from 259 753 patients with hypertension in a Swedish primary care register: results from QregPV	18
Sodium glucose co-transporter 2 inhibitors in heart failure with preserved ejection fraction: a systematic review and meta-analysis	18
The role of cardiopulmonary exercise testing in predicting mortality and morbidity in people with congenital heart disease: a systematic review and meta-analysis	18
The Moderate Alcohol and Cardiovascular Health Trial (MACH15): Design and methods for a randomized trial of moderate alcohol consumption and cardiometabolic risk	17
Congenital heart disease: changes in recorded birth prevalence and cardiac interventions over the past half-century in Sweden	17
The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy	17
A resilient type of familial hypercholesterolaemia: case–control follow-up of genetically characterized older patients in the SAFEHEART cohort	17
Profile and management of hypertensive urgencies and emergencies in the emergency cardiology department of a tertiary hospital: a 12-month registry	17
Use of sodium–glucose co-transporter 2 inhibitors and glucagon-like peptide-1 receptor agonists according to the 2019 ESC guidelines and the 2019 ADA/EASD consensus report in a national population of	17
Cardiovascular disease in the elderly: proceedings of the European Society of Cardiology—Cardiovascular Round Table	17
Prevalence and clinical implications of hyperhomocysteinaemia in patients with hypertrophic cardiomyopathy and MTHFR C6777T polymorphism	16
The relationship between blood pressure and risk of atrial fibrillation: a Mendelian randomization study	16
Sex differences in optimal medical therapy following myocardial infarction according to left ventricular ejection fraction	16
miR-181c level predicts response to exercise training in patients with heart failure and preserved ejection fraction: an analysis of the OptimEx-Clin trial	16
Incidence and prognosis of COVID-19 amongst heart transplant recipients: a systematic review and meta-analysis	16
Association of periodic fasting lifestyles with survival and incident major adverse cardiovascular events in patients undergoing cardiac catheterization	16
Age-dependent associations of body mass index with myocardial infarction, heart failure, and mortality in over 9 million Koreans	16
Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association	16
Comprehensive characterization of non-cardiac comorbidities in acute heart failure: an analysis of ESC-HFA EURObservational Research Programme Heart Failure Long-Term Registry	16
High-density lipoprotein cholesterol and cardiovascular mortality: a prospective cohort study among 15.8 million adults	16
Athletes with valvular heart disease and competitive sports: a position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology	16
Cardiovascular disease burden attributable to non-optimal temperature: analysis of the 1990–2019 global burden of disease	16
Association of Life’s Simple 7 with incident cardiovascular disease in 53 974 patients with cancer	16
Efficacy and safety of low levels of low-density lipoprotein cholesterol: trans-ancestry linear and non-linear Mendelian randomization analyses	15
Association of genetically predicted lipid traits and lipid-modifying targets with heart failure	15
Taking the next steps to implement polygenic risk scoring for improved risk stratification and primary prevention of coronary artery disease	15
Major adverse cardiovascular events in homozygous familial hypercholesterolaemia: a systematic review and meta-analysis	15
Parental cardiovascular health predicts time to onset of cardiovascular disease in offspring	15
Reference values of heart rate variability from 10-second resting electrocardiograms: the Lifelines Cohort Study	15
Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology	15
Prevalence and extent of coronary artery calcification in the middle-aged and elderly population	15
Saturated fat: villain and bogeyman in the development of cardiovascular disease?	15
Exercise intolerance and fatigue in chronic heart failure: is there a role for group III/IV afferent feedback?	15
Association of interleukin-6 and interleukin-18 with cardiovascular disease in older adults: Atherosclerosis Risk in Communities study	15
Influence of visceral adiposity accumulation on adverse left and right ventricular mechanics in the community	14
Prevalence of heart failure stages in the general population and implications for heart failure prevention: reports from the China Hypertension Survey 2012–15	14
Angiopoietin-like 3 and subclinical peripheral arterial disease: Evidence from the Brisighella Heart Study	14
Remnant cholesterol in patients admitted for acute coronary syndromes	14

HDL cholesterol and clinical outcomes in diabetes mellitus	14
New perspectives for hypertension management: progress in methodological and technological developments	14
Discordance of apolipoprotein B with low-density lipoprotein cholesterol or non-high-density lipoprotein cholesterol and coronary atherosclerosis	14
Triglyceride-rich lipoproteins, apolipoprotein C-III, angiopoietin-like protein 3, and cardiovascular events in older adults: Atherosclerosis Risk in Communities (ARIC) study	14
The need for PCSK9 inhibitors and associated treatment costs according to the 2019 ESC dyslipidaemia guidelines vs. the risk-based allocation algorithm of the 2017 ESC consensus statement: a simulatio	14
Effects of exercise training on cardiac toxicity markers in women with breast cancer undergoing chemotherapy with anthracyclines: a randomized controlled trial	14
High-intensity interval training in cardiac rehabilitation: a multi-centre randomized controlled trial	14
Lipoprotein(a) testing in clinical practice: real-life data from a large healthcare provider	14
Sex differences in type A acute aortic dissection: a systematic review and meta-analysis	14
Burden and predictors of statin use in primary and secondary prevention of atherosclerotic vascular disease in the US: from the National Health and Nutrition Examination Survey 2017–2020	14
Sex steroids and markers of micro- and macrovascular damage among women and men from the general population	14
Vegetarianism, microbiota, and cardiovascular health: looking back, and forward	13
Cardiovascular outcomes in transgender individuals in Sweden after initiation of gender-affirming hormone therapy	13
Histamine H2 receptor antagonist exposure was related to decreased all-cause mortality in critical ill patients with heart failure: a cohort study	13
Aspirin for the primary prevention of cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis	13
Epigenetics in the primary and secondary prevention of cardiovascular disease: influence of exercise and nutrition	13
Comparison of MAGGIC and MECKI risk scores to predict mortality after cardiac rehabilitation among Dutch heart failure patients	13
Plasma ceramide and phospholipid-based risk score and the risk of cardiovascular death in patients after acute coronary syndrome	13
eHealth for maintenance cardiovascular rehabilitation: a systematic review and meta-analysis	13
How to evaluate resting ECG and imaging in children practising sport: a critical review and proposal of an algorithm for ECG interpretation	12
Lifestyle interventions to change trajectories of obesity-related cardiovascular risk from childhood onset to manifestation in adulthood: a joint scientific statement of the task force for childhood h	12
Comparison of recent ceramide-based coronary risk prediction scores in cardiovascular disease patients	12
Old and new equations for maximal heart rate prediction in patients with heart failure and reduced ejection fraction on beta-blockers treatment: results from the MECKI score data set	12
Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus: A systematic review and meta-analysis	12
Cardiovascular risk assessment in people living with HIV compared to the general population	12
Non-pharmacological factors for hypertension management: a systematic review of international guidelines	12
Long Term Prognostic Impact of Sex-specific Longitudinal Changes in Blood Pressure. The EPIC-Norfolk Prospective Population Cohort Study	12
Cathepsin B expression is associated with arterial stiffening and atherosclerotic vascular disease	12
Risk and trajectory of premature ischaemic cardiovascular disease in women with a history of pre-eclampsia: a nationwide register-based study	12
Cardiac remodelling in the highest city in the world: effects of altitude and chronic mountain sickness	12
Acute effects of electronic cigarettes on vascular endothelial function: a systematic review and meta-analysis of randomized controlled trials	12
Non-exercise estimated cardiorespiratory fitness and mortality from all-causes, cardiovascular disease, and cancer in the NIH-AARP diet and health study	12
Clues and pitfalls in the diagnostic approach to cardiac masses: are pseudo-tumours truly benign?	12
Metabolic syndrome is associated with similar long-term prognosis in those living with and without obesity: an analysis of 45 615 patients from the nationwide LIPIDOGRAM 2004–2015 studies	12
Serum urate and heart failure: a bidirectional Mendelian randomization study	12
Effects of endurance exercise training on left ventricular structure in healthy adults: a systematic review and meta-analysis	12
Cardiovascular effectiveness of human-based vs. exendin-based glucagon like peptide-1 receptor agonists: a retrospective study in patients with type 2 diabetes	12
Cardiovascular health, genetic predisposition, and lifetime risk of type 2 diabetes	12
Effects of electrical muscle stimulation on physical function in frail older patients with acute heart failure: a randomized controlled trial	12
Iron deficiency in heart failure—time to redefine	12
Combinations of BMI and cardiorespiratory fitness categories: trends between 1995 and 2020 and associations with CVD incidence and mortality and all-cause mortality in 471 216 adults	11
Association of premature atherosclerotic cardiovascular disease with higher risk of cancer: a behavioral risk factor surveillance system study	11
Biventricular dysfunction and lung congestion in athletes on anabolic androgenic steroids: a speckle tracking and stress lung echocardiography analysis	11
Efficacy and safety for the achievement of guideline-recommended lower low-density lipoprotein cholesterol levels: a systematic review and meta-analysis	11
Utility of risk prediction models to detect atrial fibrillation in screened participants	11
Coronary calcification improves the estimation for clinical likelihood of obstructive coronary artery disease and avoids unnecessary testing in patients with borderline pretest probability	11
Association of inflammatory disease and long-term outcomes among young adults with myocardial infarction: the Mass General Brigham YOUNG-MI Registry	11
Global, regional, and national burden of aortic aneurysm, 1990–2017: a systematic analysis of the Global Burden of Disease Study 2017	11
Coronary microvascular dysfunction is an independent predictor of developing cancer in patients with non-obstructive coronary artery disease	11
The MECKI score initiative: Development and state of the art	11
Aspirin for primary prevention of cardiovascular outcomes in diabetes mellitus: An updated systematic review and meta-analysis	11
Proteomic profiling identifies novel independent relationships between inflammatory proteins and myocardial infarction	11
Effects of high- and low-load resistance training in patients with coronary artery disease: a randomized controlled clinical trial	11
Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy	11
Platelet-to-hemoglobin ratio as a novel predictor of long-term adverse outcomes in patients after percutaneous coronary intervention: A retrospective cohort study	11
Subclinical progression of systemic sclerosis-related cardiomyopathy	11
The built environment and cardiovascular disease: an umbrella review and meta-meta-analysis	11
The effect of high-intensity interval training on exercise capacity in post-myocardial infarction patients: a systematic review and meta-analysis	11
Current perceptions and practices in lipid management: results of a European Society of Cardiology/European Atherosclerosis Society Survey	11
Obesity in heart failure with preserved ejection fraction with and without diabetes: risk factor or innocent bystander?	11
Comparison among different multiparametric scores for risk stratification in heart failure patients with reduced ejection fraction	11
Validation and comparison of 28 risk prediction models for coronary artery disease	11
Measuring lipoprotein(a): do it without ifs and buts	11
High heart rate amplifies the risk of cardiovascular mortality associated with elevated uric acid	10
Effect of the LDL receptor mutation type on incident major adverse cardiovascular events in familial hypercholesterolaemia	10
The effect of mobile health focused on diet and lifestyle on blood pressure: a systematic review and meta-analysis	10
C-reactive protein and cardiovascular diseases: a synthesis of studies based on different designs	10
The effect of living environmental factors on cardiovascular diseases in Chinese adults: results from a cross-sectional and longitudinal study	10
Prognostic benefit of early diagnosis with exercise stress testing in heart failure with preserved ejection fraction	10
Overview of Cardiac Rehabilitation following post-acute myocardial infarction in European Society of Cardiology member countries	10
Exercise oscillatory breathing in heart failure with reduced ejection fraction: clinical implication	10
Association between NMR metabolomic signatures of healthy lifestyle and incident coronary artery disease	10
Prenatal exposure to the Chinese famine of 1959–62 and risk of cardiovascular diseases in adulthood: findings from the China PEACE million persons project	10
Integrated care for atrial fibrillation: the heart of the matter	10
Effect of persistent opium consumption after surgery on the long-term outcomes of surgical revascularisation	10
Supervised aquatic-based exercise for men with coronary artery disease: a meta-analysis of randomised controlled trials	10
Circulating microRNA as predictors for exercise response in heart failure with reduced ejection fraction	10
Impact of diabetes on coronary severity and cardiovascular outcomes in patients with heterozygous familial hypercholesterolaemia	10
Sex-specific temporal trends in the incidence and prevalence of cardiovascular disease in young adults: a population-based study using UK primary care data	10
Dose-dependent relationship of blood pressure and glycaemic status with risk of aortic dissection and aneurysm	10
Prognostic impact of type 1 and type 2 diabetes mellitus in atrial fibrillation and the effect of severe hypoglycaemia: a nationwide cohort study	10
Associations between the neighbourhood food environment and cardiovascular disease: a systematic review	10
Risk factor variability and cardiovascular risk among patients with diabetes: a nationwide observational study	10
Comprehensive multicomponent cardiac rehabilitation in cardiac implantable electronic devices recipients: a consensus document from the European Association of Preventive Cardiology (EAPC; Secondary p	10
Alcohol consumption and subclinical and clinical coronary heart disease: a Mendelian randomization analysis	10
Activation of invariant natural killer T cells by alpha-galactosylceramide ameliorates doxorubicin-induced cardiotoxicity in mice	10
Visceral adiposity index and the risk of heart failure, late-life cardiac structure, and function in ARIC study	10
Prospective relationship between occupational physical activity and risk of ischaemic heart disease: are men and women differently affected?	9
Is the SMART risk prediction model ready for real-world implementation? A validation study in a routine care setting of approximately 380 000 individuals	9
Worldwide trends in mortality for hypertensive heart disease from 1990 to 2019 with projection to 2034: data from the Global Burden of Disease 2019 study	9
Causal associations of sleep apnea, snoring with cardiovascular diseases, and the role of body mass index: a two-sample Mendelian randomization study	9
The underutilization of preventive cardiovascular measures in patients with cancer: an analysis of the Behavioural Risk Factor Surveillance System, 2011–22	9
The interplay of endothelial dysfunction, cardiovascular disease, and cancer: What we should know beyond inflammation and oxidative stress	9
Relation of maximal systolic blood pressure during exercise testing to the risk of sudden cardiac death in men with and without cardiovascular disease	9
Reference values of aerobic fitness in the contemporary paediatric population	9